Lingzhi for Cancer Children
NCT00575926
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
58
Enrollment
OTHER
Sponsor class
Conditions
Pediatric Cancers
Interventions
DRUG:
LingZhi capsule
Sponsor
Chinese University of Hong Kong
Collaborators
[object Object]
[object Object]
[object Object]